Patents Assigned to University
-
Patent number: 10577601Abstract: The invention provides methods for preparing DNA sequencing libraries by assembling short read sequencing data into longer contiguous sequences for genome assembly, full length cDNA sequencing, metagenomics, and the analysis of repetitive sequences of assembled genomes.Type: GrantFiled: May 12, 2017Date of Patent: March 3, 2020Assignee: University of WashingtonInventors: Jay Shendure, Joseph Hiatt, Rupali Patwardhan, Emily Turner
-
Patent number: 10577677Abstract: Systems and methods for recovering rare earth metals from rare earth metal-containing magnets includes fragmenting or commutating the magnets, contacting the commutated magnets with a mixture of low molecular weight carboxylic acids such as formic acid and water, and removing or extracting non-rare earth metal carboxylate phases such as an iron carboxylate (formate) phase from a rare earth metal carboxylate (formate) phase, using a solvent such as water.Type: GrantFiled: July 11, 2016Date of Patent: March 3, 2020Assignee: University of Houston SystemInventors: Allan J. Jacobson, Pradeep Samarasekere
-
Patent number: 10577701Abstract: The present disclosure relates to a heterojunction composite including: a chalcogenide metal compound dispersed on a substrate, and all or a part of the substrate is chalcogenized in the same manner as the chalcogenide metal compound.Type: GrantFiled: March 29, 2018Date of Patent: March 3, 2020Assignee: Research & Business Foundation Sungkyunkwan UniversityInventors: Changdeuck Bae, Hyunjung Shin
-
Patent number: 10580924Abstract: Devices and methods for Terahertz (THz) sensing/detection, imaging, spectroscopy, and communication are provided. A graphene-based field effect transistor (FET) can have a quality factor of greater than 400 and a responsivity of at least 400 Volts per Watt. A FET sensor can include a substrate, a gate disposed on the substrate, an insulation layer disposed on the gate and the substrate, a source terminal and a drain terminal disposed on the substrate, and a graphene layer disposed on the insulation layer.Type: GrantFiled: February 28, 2019Date of Patent: March 3, 2020Assignee: The Florida International University Board of TrusteesInventors: Mustafa Karabiyik, Nezih Pala
-
Patent number: 10577431Abstract: Disclosed herein are monoclonal antibodies or binding portion thereof that bind specifically to a Staphylococcus spp. autolysin N-acetylmuramoyl-L-alanine amidase catalytic domain and/or cell wall binding domain, as well as pharmaceutical compositions containing the same. Cell lines expressing the monoclonal antibodies, including hybridomas, are also disclosed. Methods of using the monoclonal antibodies for installation of orthopedic implants, grafts or medical devices, treating or preventing a Staphylococcus infection, and treating osteomyelitis are described, as are diagnostic methods for the detection of Staphylococcus in a sample.Type: GrantFiled: October 15, 2018Date of Patent: March 3, 2020Assignee: University of RochesterInventors: John L. Daiss, Edward Schwarz, John J. Varrone, James Brodell, Sheila Bello-Irizarry
-
Patent number: 10577610Abstract: The present disclosure relates to an EpCAM aptamer or an EpCAM aptamer conjugate having bi-functional activity and to uses thereof. In particular, the present disclosure also relates to an aptamer conjugate which binds to the transferrin receptor (TfR) and EpCAM which is useful for treatment of brain tumours and/or brain metastasis.Type: GrantFiled: February 11, 2016Date of Patent: March 3, 2020Assignee: Deakin UniversityInventor: Sarah Shigdar
-
Patent number: 10575787Abstract: A hydration sensor is provided that includes a circulator having a plurality of ports, an amplitude-modulated coherent source connected to a first port of the circulator, a rectifier or other power sensor connected to a second port of the circulator followed by an RF baseband low-noise amplifier, a coupling structure connected to the third port of the circulator, and a demodulator connected to the output of the rectifier. The hydration sensor can include an RF low noise amplifier between the circulator and rectifier, and/or a second amplitude modulator between the circulator and the coupling structure. The coupling structure can be either a guided-wave near-field structure or an interfacial capacitive or inductive element. In the former case, the hydration is determined by measuring the reflectivity of the guided-wave radiation, and in the latter case it is determined by measuring the change of reflectivity (through change of impedance) of the interfacial element.Type: GrantFiled: April 17, 2017Date of Patent: March 3, 2020Assignee: Wright State UniversityInventors: Elliott R. Brown, Weidong Zhang
-
Patent number: 10576305Abstract: Described herein is an implantable device having a sensor configured to detect an amount of an analyte, a pH, a temperature, strain, or a pressure; and an ultrasonic transducer with a length of about 5 mm or less in the longest dimension, configured to receive current modulated based on the analyte amount, the pH, the temperature, or the pressure detected by the sensor, and emit an ultrasonic backscatter based on the received current. The implantable device can be implanted in a subject, such as an animal or a plant. Also described herein are systems including one or more implantable devices and an interrogator comprising one or more ultrasonic transducers configured to transmit ultrasonic waves to the one or more implantable devices or receive ultrasonic backscatter from the one or more implantable devices. Also described are methods of detecting an amount of an analyte, a pH, a temperature, a strain, or a pressure.Type: GrantFiled: April 10, 2019Date of Patent: March 3, 2020Assignee: The Regents of the University of CaliforniaInventors: Michel M. Maharbiz, Jose M. Carmena, Mekhail Anwar, Burak A. Ozilgen, Dongjin Seo, Federica Fava
-
Patent number: 10580129Abstract: Methods and systems that detect and differentiate epileptogenic from eloquent and normal cortices are provided. A method for identifying epileptogenic cortices in a brain may include detecting areas in the brain that are undergoing cerebral blood volume low frequency oscillations, detecting areas in the brain that are undergoing blood oxygenation low frequency oscillations; mapping clusters of the brain in which the cerebral blood volume low frequency oscillations are negatively correlated with the blood oxygenation low frequency oscillations, and analyzing the time based relationship between the clusters of the brain that are undergoing negatively correlated low frequency oscillations to determine cause areas, which are areas of the brain that are causing negatively correlated low frequency oscillations to occur elsewhere.Type: GrantFiled: May 27, 2016Date of Patent: March 3, 2020Assignee: The Florida International University Board of TrusteesInventors: Wei-Chiang Lin, Yinchen Song
-
Patent number: 10577321Abstract: Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.Type: GrantFiled: July 7, 2016Date of Patent: March 3, 2020Assignees: University of Southern California, CV6 Therapeutics (NI) LimitedInventors: Robert D. Ladner, Mark Spyvee, Pravin S. Shirude
-
Patent number: 10576271Abstract: Systems, methods, and devices are disclosed for optimizing patient-specific stimulation parameters for spinal cord stimulation. A patient-specific anatomical model is developed based on a pre-operative image, and a patient-specific electrical model is developed based on the anatomical model. The inputs to the electric model are chosen, and the model is used to calculate a distribution of electrical potentials within the modeled domain. Models of neural elements are stimulated with the electric potentials and used to determine which elements are directly activated by the stimulus. Information about the models inputs and which neural elements are active is applied to a cost function. Based on the value of the cost function, the inputs to the optimization process may be adjusted. Inputs to the optimization process include lead/electrode array geometry, lead configuration, lead positions, and lead signal characteristics, such as pulse width, amplitude, frequency and polarity.Type: GrantFiled: December 18, 2017Date of Patent: March 3, 2020Assignee: Duke UniversityInventors: Warren M. Grill, Bryan Howell, Shivanand P. Lad
-
Patent number: 10579166Abstract: The present disclosure describes systems, methods, and apparatuses utilizing pointer acceleration system modeling. In one exemplary method, among others, such a method obtains, a closed loop pointer acceleration system model, in which the closed loop pointer acceleration system model is based on (1) a model describing user pointing motions integrated with (2) a model of pointer acceleration motions under operational conditions; obtains values for system parameters that include pointer acceleration profile parameters and operational condition parameters; and determines a set of pointer trajectories for a given acceleration profile having the pointer acceleration profile parameters and operational condition parameters.Type: GrantFiled: April 5, 2018Date of Patent: March 3, 2020Assignees: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Georgia Tech Research CorporationInventors: Michael Malisoff, Fumin Zhang, Jesse Paul Varnell
-
Patent number: 10580869Abstract: A stacked body includes: a substrate made of silicon carbide and having a first main surface forming an angle of 20° or less with a silicon plane; and a graphene film disposed on the first main surface and having an atomic arrangement oriented in relation to an atomic arrangement of silicon carbide forming the substrate. In an exposed surface of the graphene film which is a main surface opposite to the substrate, an area ratio of a region having a full width at half maximum of G? of 40 cm?1 or less under Raman spectroscopy analysis is 50% or more. Accordingly, the stacked body is provided that enables a high mobility to be stably ensured in an electronic device manufactured to include the graphene film forming an electrically conductive portion.Type: GrantFiled: April 19, 2017Date of Patent: March 3, 2020Assignees: Sumitomo Electric Industries, Ltd., Tohoku UniversityInventors: Masaya Okada, Fuminori Mitsuhashi, Yasunori Tateno, Masaki Ueno, Maki Suemitsu, Hirokazu Fukidome
-
Patent number: 10581338Abstract: A power supply system includes a plurality of AC output converters connected in parallel for supplying electric power to an AC load. Each of the plurality of AC output converters includes an output impedance connected to the AC load, a PWM converter configured to convert DC power into AC power, and a controller configured to output a voltage command value to the PWM converter. The controller includes a vector adder configured to perform vector addition of a part of a voltage drop occurring due to a current flowing through the output impedance and a voltage command value of the AC load, and a converter configured to output a voltage command value to the PWM converter based on a vector sum obtained through the vector addition.Type: GrantFiled: September 14, 2016Date of Patent: March 3, 2020Assignees: National University Corporation YOKOHAMA National University, TOSHIBA MITSUBISHI-ELECTRIC INDUSTRIAL SYSTEMS CORPORATIONInventors: Atsuo Kawamura, Mohammad Bani Shamseh, Teruo Yoshino
-
Patent number: 10577404Abstract: Derivative polypeptide derived from a grass carp interferon and an application of the derivative polypeptide. An amino acid sequence of the derivative polypeptide is as shown in SEQ ID NO:1; the interferon-derived polypeptide has a high-efficiency antibacterial effect and can take effect against drug-resistant Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus agalactiae, Vibrio fluvialis or Aeromonas hydrophila. The interferon-derived polypeptide is less toxic to eukaryotes and can effectively reduce the mortality of mice in a mouse disease model caused by pathological bacteria. The interferon-derived polypeptide which is small in molecular weight is easily synthesized and has a good application value.Type: GrantFiled: May 22, 2019Date of Patent: March 3, 2020Assignee: Huazhong Agricultural UniversityInventors: Jianguo Su, Xun Xiao, Wentao Zhu
-
Patent number: 10576151Abstract: Modulation of glucose homeostasis by administration of ciclopirox (6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one) is described. Methods can be utilized in treatment of conditions that involve loss of glucose homeostasis, such as diabetes, and in one particular embodiment type II diabetes. Ciclopirox is shown to stimulate p21 expression by mechanisms that are likely p53-independent.Type: GrantFiled: September 14, 2016Date of Patent: March 3, 2020Assignee: University of South CarolinaInventors: Ioulia Chatzistamou, Hippokratis Kiaris, Chrysovalantou Mihailidou
-
Patent number: 10576272Abstract: This invention provides a device for implantation directly into the spinal cord for the purpose of treating back pain. Electrodes on a backing that conforms directly to the spinal cord are installed as a source of electrical stimulation and pain relief. The floating electrodes can be flexibly mounted to the substrate such that when the electrode array is implanted into the subject, individual electrodes float or move resiliently relative to the substrate to an extent sufficient to accommodate pulsations of the surface of the spinal cord within the dura.Type: GrantFiled: August 30, 2018Date of Patent: March 3, 2020Assignee: University of Iowa Research FoundationInventor: Matthew A. Howard
-
Patent number: 10581173Abstract: In some embodiments, an antenna includes a dielectric substrate having a first surface and a second surface opposite to the first surface, a planar central antenna element provided on the first surface, and a planar electromagnetic bandgap structure provided on the first surface and surrounding the central antenna element.Type: GrantFiled: April 3, 2018Date of Patent: March 3, 2020Assignee: University of South FloridaInventors: Michael Dante Grady, Thomas McCrea Weller
-
Patent number: 10575537Abstract: The present invention discloses a saury Maillard peptide with antihyperuricemic activity and its preparation method and application, with the method comprising the following steps: mincing a saury, adding water, heating, agitating, adjusting a pH value to 4.2, separating by centrifugation, and collecting the precipitate; adding water, proteases and amino acids to the precipitate, adjusting a pH value to 7.0, hydrolyzing, adding a reducing sugar to cause a reaction, centrifuging and collecting a supernatant which is saury Maillard peptide; and spray drying the peptide liquid to obtain a dry powder. The method of the present invention realizes the continuous action of enzymolysis and Maillard reaction to prepare the Maillard peptide, not only simplifying the production process, shortening the production cycle, and reducing the production costs, but also significantly enhancing the antihyperuricemic activity of the produced Maillard peptide.Type: GrantFiled: December 23, 2015Date of Patent: March 3, 2020Assignee: South China University of TechnologyInventors: Mouming Zhao, Qiangzhong Zhao, Guowan Su, Yang Liu, Lianzhu Lin, Rongzhong Zhao
-
Patent number: 10576426Abstract: A plasma separator includes a vertical chamber with a membrane or membranes partially or fully covering the internal chamber walls and forming an inner cavity to accommodate whole blood. The plasma separator further includes a plasma collection space separated from the inner cavity with one or more membranes and a plasma removal port.Type: GrantFiled: December 18, 2014Date of Patent: March 3, 2020Assignee: The Trustees of the University of PennsylvaniaInventors: Changchun Liu, Haim H. Bau, Michael G. Mauk